0.601
0.02 (3.82%)
| Previous Close | 0.579 |
| Open | 0.585 |
| Volume | 482,575 |
| Avg. Volume (3M) | 826,034 |
| Market Cap | 27,586,382 |
| Price / Sales | 3.79 |
| Price / Book | 1.05 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2024 |
| Operating Margin (TTM) | -1,021.64% |
| Diluted EPS (TTM) | -1.00 |
| Quarterly Revenue Growth (YOY) | 174.20% |
| Total Debt/Equity (MRQ) | 58.31% |
| Current Ratio (MRQ) | 3.56 |
| Operating Cash Flow (TTM) | -41.99 M |
| Levered Free Cash Flow (TTM) | -30.04 M |
| Return on Assets (TTM) | -72.62% |
| Return on Equity (TTM) | -262.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Beyond Air, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -1.0 |
| Average | -1.25 |
|
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 14.02% |
| % Held by Institutions | 23.39% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |